EUVIMEDEUVIMED entdecken
Kohortenstudie

Effect of glucagon-like peptide-1 receptor agonist on outcomes after elective total hip arthroplasty: A retrospective cohort study

Troy Puga, McKenna W Box, Andrew Jen, Yingxian Liu, John T Riehl

Journal of Orthopaedic Science · 2026

DOI: 10.1016/j.jos.2026.02.002 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Orthopaedic Science, 2026. Verfasst von Troy Puga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Surgery Residency Program, Medical City Denton, Denton, TX, United States. Electronic address: troypugaorthopaedics@gmail.com. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Postoperative Complications, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate medical and surgical outcomes postoperatively for patients using GLP-1RA at the time of undergoing THA surgery, with a focus on early 30 day medical complications and 1 year surgical complications. METHODS: This was a retrospective cohort study. Current Procedural Terminology (CPT) and International Classification of Diseases (ICD)-10 codes were utilized to identify patients. Patients were placed into two groups based on whether they were on a GLP-1RA or not. Sex, age, body mass index (BMI), smoking status, and Elixhauser comorbidity index (ECI) and diabetes status were control variables. Outcomes studied were surgical site infection (SSI), medical complications, all-cause readmissions, implant complications, revision THA, and in-hospital mortality or discharge to hospice. RESULTS: 13,206 patients met inclusion criteria. 335 (2.5 %) patients were on a GLP-1RA. In both cohorts, GLP-1RA users were younger, had higher BMIs, and more comorbidities than those not on GLP-1RA (p < 0.05). At 30 days postoperatively patients taking GLP-1RA experienced higher rates of pulmonary embolism (PE) (p = 0.004), acute kidney injury (AKI) (p = 0.006), hypoglycemia (p < 0.001), and overall complications (p < 0.001) compared with patients not receiving GLP-1RA. However, when bivariate logistic regression analyses, controlling for age, sex, BMI, smoking status, ECI, and diabetes status was undertaken, GLP-1RA use was not associated with elevated risks of adverse outcomes at 30 days for medical complications (Odds Ratio (OR): 1.611; 95 % Confidence Interval (CI) 0.881-2.947, p = 0.1215). Bivariate logistic regression also revealed no difference in complications for 90 days readmission or SSI, and 1 year postoperative surgical outcomes or readmissions. CONCLUSIONS: The results suggest that GLP-1RA use was not associated with any statistical difference in overall medical complications at 30 days, 90 day readmissions or SSI, or 1 year postoperative surgical outcomes when patients undergo THA while taking a GLP-1RA medication when controlling for confounding variables. GLP-1RA medications do not appear to be associated with increased risk of complications for patients undergoing THA, however, future studies can further evaluate if complications exist.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipPostoperative ComplicationsGlucagon-Like Peptide-1 Receptor AgonistsHumansFemaleRetrospective StudiesMaleAgedElective Surgical ProceduresTreatment OutcomeMiddle AgedCohort Studies

Stichwörter der Autor:innen

DiabetesGLP-1 agonistsOutcomesTotal hip arthroplasty

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Orthopaedic Surgery Residency Program, Medical City Denton, Denton, TX, United States. Electronic address: troypugaorthopaedics@gmail.com.
  • Orthopaedic Surgery Residency Program, Medical City Denton, Denton, TX, United States.
  • Orthopaedic Surgery Residency Program, Medical City Denton, Denton, TX, United States; Texas Bone and Joint, Fort Worth, Texas, United States.
  • Physician Services Group, Graduate Medical Education, HCA Healthcare, Brentwood, TN, United States.

Zitieren

APA

Puga, T., Box, M. W., Jen, A., Liu, Y., & Riehl, J. T. (2026). Effect of glucagon-like peptide-1 receptor agonist on outcomes after elective total hip arthroplasty: A retrospective cohort study. Journal of Orthopaedic Science. https://doi.org/10.1016/j.jos.2026.02.002

Vancouver

Puga T, Box MW, Jen A, Liu Y, Riehl JT. Effect of glucagon-like peptide-1 receptor agonist on outcomes after elective total hip arthroplasty: A retrospective cohort study. Journal of Orthopaedic Science. 2026. doi:10.1016/j.jos.2026.02.002

BibTeX
@article{Puga2026,
  author = {Puga, Troy and Box, McKenna W and Jen, Andrew and Liu, Yingxian and Riehl, John T},
  title = {Effect of glucagon-like peptide-1 receptor agonist on outcomes after elective total hip arthroplasty: A retrospective cohort study},
  journal = {Journal of Orthopaedic Science},
  year = {2026},
  doi = {10.1016/j.jos.2026.02.002}
}
Kostenlos starten →